| Oct 2 |
Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases
|
| Sep 26 |
Is Vera Therapeutics Inc. (VERA) the Best Performing Small-Cap Stock in 2024?
|
| Sep 16 |
Vera Therapeutics to Host In-Person R&D Day in New York to Discuss Potential Indication Expansion for Atacicept on October 2, 2024
|
| Sep 12 |
Vera Therapeutics Completes Enrollment for Primary Endpoint in Pivotal Phase 3 ORIGIN 3 Trial of Atacicept in IgAN
|
| Sep 5 |
Vera Therapeutics, Inc. (VERA): Among the Best Mid-Cap Healthcare Stocks To Buy Now
|
| Sep 3 |
Load Up on Adobe and These 2 Stocks This September, J.P. Morgan Says
|
| Aug 29 |
Vera Therapeutics to Participate at September Investor Conferences
|
| Aug 13 |
Vera Therapeutics, Inc.'s (NASDAQ:VERA) Intrinsic Value Is Potentially 88% Above Its Share Price
|
| Aug 8 |
Vera Therapeutics GAAP EPS of -$0.62 misses by $0.06
|
| Aug 8 |
Vera Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
|
